AMSTERDAM, Netherlands and YORK, Pa., June 4, 2026
Royal Philips and WellSpan Health have announced a landmark seven-year strategic alliance designed to accelerate healthcare innovation, expand advanced diagnostics capabilities, and establish one of the most comprehensive community health research collaborations in the United States. The partnership combines Philips’ global leadership in healthcare technology with WellSpan’s extensive clinical network across Central Pennsylvania and Northern Maryland, creating a platform for the development and validation of next-generation artificial intelligence (AI), diagnostic imaging, and digital health solutions. The agreement positions WellSpan at the forefront of healthcare transformation and demonstrates how community health systems can play a critical role in shaping the future of patient care through technology-driven innovation.
Advancing AI and Digital Healthcare Innovation
At the center of the alliance is a groundbreaking research and innovation framework focused on evaluating how emerging technologies can improve healthcare delivery. The collaboration will support the validation of new AI-powered diagnostic tools, digital workflows, and advanced imaging technologies designed to improve operational efficiency, patient outcomes, and workforce productivity. Research initiatives will examine how artificial intelligence can optimize clinical throughput, reduce operational costs, streamline workflows, and enhance decision-making across healthcare settings.
A key objective of WellSpan’s innovation strategy is to reclaim more than 500,000 workforce hours annually, allowing healthcare professionals to dedicate more time to direct patient care. By leveraging real-world clinical environments, the alliance aims to generate evidence supporting broader adoption of AI-driven healthcare solutions while accelerating the translation of innovative technologies into routine clinical practice.
New Research Platform to Shape Future Care Delivery
A major component of the agreement establishes WellSpan as both a research partner and co-developer of future healthcare technologies. Through collaboration with Philips Research, the organizations will jointly design, test, and refine new products and features that address evolving clinical and operational challenges. This marks the first collaboration of its kind between Philips and a U.S. community health system, creating a unique innovation ecosystem where clinicians, researchers, engineers, and technology developers work together to advance patient care.
WellSpan will serve as a real-world proving ground for emerging healthcare technologies, helping Philips evaluate next-generation solutions before broader market deployment. The partnership reflects a growing trend toward collaborative healthcare innovation, where technology companies and health systems co-create solutions that directly address frontline clinical needs while improving healthcare accessibility and quality.
Expanding Advanced Imaging and Diagnostic Capabilities
The strategic alliance also includes a long-term commercial agreement that designates Philips as WellSpan’s preferred technology partner across all major imaging modalities, including computed tomography (CT), magnetic resonance imaging (MRI), digital X-ray, ultrasound, and image-guided therapy systems. The agreement spans all 12 WellSpan hospitals, diagnostic imaging centers, and ambulatory surgery facilities, ensuring a consistent patient experience across the health system. A defining feature of the collaboration is its comprehensive technology lifecycle management approach, which aligns equipment deployment, service support, workforce training, maintenance planning, and future upgrades under a coordinated framework.
This model is expected to improve imaging availability, reduce technology-related disruptions, and strengthen patient access to advanced diagnostic services. By integrating cutting-edge imaging platforms with AI-enabled clinical workflows, Philips and WellSpan aim to establish a scalable model for modern healthcare delivery that enhances clinical performance while supporting long-term innovation.
The alliance highlights the increasing role of AI, digital health platforms, and advanced diagnostics in transforming healthcare systems worldwide. By combining research, technology development, and large-scale clinical implementation, Philips and WellSpan are creating a framework that could influence how community healthcare organizations adopt and deploy innovative technologies for years to come.
Source: Philips press release



